Blueshift Asset Management »

Cytokinetics shares owned by Blueshift Asset Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Blueshift Asset Management from 13F filings

Historical chart of Blueshift Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Blueshift Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Blueshift Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $234k 3.7k 63.54
2021-12-31 $383k 8.4k 45.62
2021-09-30 $475k 13k 35.71
2021-03-31 $211k 9.1k 23.21

More positions owned by Blueshift Asset Management

Ishares Tr Ussell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr R Unit (SPY)
Match Group Om (MTCH)
Deckers Outdoor Corp Om (DECK)
Dicks Sporting Goods Om (DKS)
Roblox Corp L A (RBLX)
Amer Sports Com Shs (AS)
Hertz Global Hldgs Om New (HTZ)
Roku Om Cl A (ROKU)
Carters Om (CRI)
Dollar General (DG)
Keurig Dr Pepper Om (KDP)
Sharkninja Om Shs (SN)
Bath & Body Works Om (BBWI)
Ollies Bargain Outlt Hldgs I (OLLI)

View all positions for Blueshift Asset Management

Top funds holding Cytokinetics

T. Rowe Price Investment Management
BlackRock
FMR
Vanguard Group
Wellington Management Company
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
Geode Capital Management
Bank of America Corporation
Susquehanna International
Rtw Investments
Armistice Capital
Goldman Sachs Group
Polar Capital Holdings

View all funds holding Cytokinetics